Skip to content

News & updates

Press Releases

MiRXES launches Japan subsidiary

1 June, 2020

MiRXES to mass produce and distribute A*STAR Singapore’s tested and proven SARS-CoV-2 RT-PCR test

23 April, 2020

MiRXES collaborates with NUS and DxD Hub to move Singapore to the forefront of global microRNA research and application

29 January, 2020

MiRXES to collaborate with Beth Israel Deaconess Medical Centre

26 June, 2018

MiRXES, Johnson & Johnson and Janssen unite for early detection of lung cancer

10 January, 2018

MiRXES partners Janssen R&D to advance early detection of diabetes

22 March, 2016
« Prev12Next »

Media Coverage

MiRXES and other homegrown firms in virus fight
11 August, 2020 /
The fast track to Fortitude Kit for rapid COVID-19 diagnosis
27 July, 2020 / ,
Webinar featuring MiRXES CEO: Perspectives from behind-the-scenes of COVID-19 testing
21 July, 2020 /
How MiRXES scaled from cancer to COVID-19
11 June, 2020 /
Biotech firms race against time to get around logistical challenges
23 May, 2020 /
MiRXES leading the way in microRNA technology
21 May, 2020 /
Home-grown firms linked to pandemic work will continue to attract demand, investments
10 May, 2020 /
MiRXES’ role in Singapore’s pivot to mass COVID-19 tests
8 May, 2020 /
MiRXES is 102nd on Financial Times ranking of Asia-Pacific High Growth Companies
21 April, 2020 /
COVID-19 putting MiRXES and Singapore on global deeptech radar
14 April, 2020 /
MiRXES heeding the call for COVID-19 testing
30 March, 2020 /
MiRXES and Singapore scientists on the front lines of fight against COVID-19
25 March, 2020 /
MiRXES — A game changer in microRNA applications
3 March, 2020 /
Singapore clears Fortitude Kit SARS-CoV-2 test for clinical use
3 March, 2020 /
MiRXES to mass-produce Singapore-developed Fortitude Kit SARS-CoV-2 test kits
18 February, 2020 / ,
MiRXES named Singapore’s fastest growing company in the health sector from 2015-2018
15 January, 2020 /
Timely guidance for MiRXES from Pro-Enterprise Panel
7 November, 2019 /
GASTROClear blood test for stomach cancer first step to ending all cancer deaths
18 September, 2019 /
MiRXES has a real shot at stamping out cancer deaths
8 July, 2019 /
Seniors tested for stomach cancer with GASTROClear at free screening in Teck Ghee
18 May, 2019 /
MiRXES’ holding company raises US$40M to expand its non-invasive cancer detection technologies in Asia
27 November, 2018 /
MiRXES’ holding company clinches $55.03m funding
27 November, 2018 /
MiRXES team gets funding to ‘eliminate late-stage cancer’
27 November, 2018 /
MiRXES’ holding company launched with US$40m Series A funding
27 November, 2018 /
Promising biomedical start-ups in Singapore – MiRXES
28 June, 2018 /
MiRXES co-founder Zhou Lihan’s entrepreneurial journey
14 May, 2018 /
MiRXES collaborates with Johnson & Johnson to develop miRNA test for lung cancer
16 January, 2018 /
MiRXES aims to make cancer tests more accessible
21 November, 2016 /
Venturecraft invests in MiRXES
6 September, 2016 /
« Prev12Next »